Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Home Reported Outcomes in C3G Study

for
C3 Glomerulopathy
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07029542

Recruiting

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

for
Early Breast Cancer
Location: New Brunswick NJ, East Brunswick NJ, Norwich CT,
Sponsor: Genentech, Inc.

Sex: Female

Age: 18+

Code: NCT07541079

Phase 3, Recruiting

Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)

for
Bladder Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07762586

Phase 2, Recruiting

A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.

for
Melanoma (Skin Cancer)
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT07830225

Recruiting

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

for
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma,
Location: New Brunswick NJ, Long Branch NJ, Danville IL,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07504588

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for
Breast Neoplasms, Breast Cancer
Location: New Brunswick NJ, Boston MA, Fairfax VA, Kingston,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase 1, Phase 2, Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

for
Gastric Cancer, Breast Cancer, Cervical Cancer, Lung Cancer
Location: New Brunswick NJ
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05483491

Phase 1, Recruiting

Addressing Genomic Disparities in Cancer Survivors

for
Hereditary Cancer, Genetic Testing
Location: New Brunswick NJ, Washington D.C. DC
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18 - 70+

Code: NCT06073626

Recruiting

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC,
Location: Morristown NJ, Fairfax VA, Columbus OH,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07085091

Phase 1, Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

for
Advanced Solid Malignancies
Location: New Brunswick NJ, Richmond VA, Louisville KY,
Sponsor: Georgiamune Inc

Sex: All

Age: 18+

Code: NCT06028074

Phase 1, Phase 2, Recruiting

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

for
Leiomyosarcoma
Location: New Brunswick NJ, Columbus OH, Jacksonville FL,
Sponsor: Philogen S.p.A.

Sex: All

Age: 16 - 70+

Code: NCT03420014

Phase 2, Recruiting

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

for
Solid Tumors With HRAS Alterations,
Location: New Brunswick NJ, Boston MA, Pittsburgh PA, Columbus OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06026410

Phase 1, Recruiting

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

for
Follicular Lymphoma
Location: New Brunswick NJ, Ann Arbor MI, Miami FL
Sponsor: Juan P. Alderuccio, MD

Sex: All

Age: 18+

Code: NCT04998669

Phase 2, Recruiting

MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

for
Melanoma
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05373823

Recruiting

Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer

for
Breast Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT05736367

Recruiting

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

for
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma,
Location: New Brunswick NJ
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05639972

Phase 1, Phase 2, Recruiting

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

for
Cervical Cancer, Throat Cancer, Oropharynx Cancer, Anal Cancer,
Location: New Brunswick NJ, Bethesda MD
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05686226

Phase 2, Recruiting

Naltrexone and Propranolol Combined With Immunotherapy

for
Advanced Melanoma
Location: New Brunswick NJ
Sponsor: Sarah Weiss

Sex: All

Age: 18+

Code: NCT05968690

Phase 1, Recruiting

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: New Brunswick NJ, New Haven CT, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT05125016

Phase 1, Phase 2, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase 2, Recruiting